This antioxidant activity may help reduce damage to the skin cells and promote a more youthful appearance
Ongoing clinical trials and strong pharmaceutical investments are accelerating adoption and market expansion
We chose the GK rats since they spontaneously develop T2DM without obesity and mild renal damage, and the DPP-4 inhibitor sitagliptin is one of the drugs commonly used for the treatment of T2DM in CKD patients due to its safety profile
Early-life polyphenol intake promotes Akkermansia growth and increase of host goblet cells in association with the potential synergistic effect of Lactobacillus
"For many people with type 2 diabetes, it is a struggle to achieve both A1C control and weight loss, since obesity has historically been harder to treat for those with type 2 diabetes," Kenneth Custer, executive vice president and president of Lilly Cardiometabolic Health, said in a press release
10.1093/ajcn/66.1.116 20 GiovannucciE.PollakM